BeiGene Ltd (BGNE)
194.56
+0.30
(+0.15%)
USD |
NASDAQ |
Nov 21, 16:00
194.76
+0.20
(+0.10%)
After-Hours: 20:00
BeiGene Gross Profit Margin (Quarterly): 82.98% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 82.98% |
| June 30, 2024 | 85.13% |
| March 31, 2024 | 83.38% |
| December 31, 2023 | 83.32% |
| September 30, 2023 | 87.67% |
| June 30, 2023 | 83.87% |
| March 31, 2023 | 81.74% |
| December 31, 2022 | 80.66% |
| September 30, 2022 | 80.25% |
| June 30, 2022 | 79.16% |
| March 31, 2022 | 78.72% |
| December 31, 2021 | 77.31% |
| September 30, 2021 | 77.03% |
| June 30, 2021 | 75.82% |
| March 31, 2021 | 94.61% |
| Date | Value |
|---|---|
| December 31, 2020 | 78.94% |
| September 30, 2020 | 76.81% |
| June 30, 2020 | 78.20% |
| March 31, 2020 | 72.82% |
| December 31, 2019 | 68.39% |
| September 30, 2019 | 59.90% |
| June 30, 2019 | 92.67% |
| March 31, 2019 | 80.39% |
| December 31, 2018 | 84.33% |
| September 30, 2018 | 83.94% |
| June 30, 2018 | 88.15% |
| March 31, 2018 | 86.02% |
| December 31, 2017 | 83.33% |
| September 30, 2017 | 99.12% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
68.39%
Minimum
Dec 2019
94.61%
Maximum
Mar 2021
80.34%
Average
79.71%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Theravance Biopharma Inc | -- |
| Merck & Co Inc | 75.51% |
| Bristol-Myers Squibb Co | 75.13% |
| Zai Lab Ltd | 63.90% |
| Halozyme Therapeutics Inc | 82.96% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.64% |
| Return on Assets | -15.07% |
| Return on Invested Capital | -19.56% |
| Profit Margin (Quarterly) | -12.12% |
| Operating Margin (Quarterly) | -12.01% |
| Return on Net Operating Assets | -32.56% |